NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/05/2023
Back to search
Official data from USPTO
A-KINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/05/2023
Trademark type
Word
Nice classes
1, 5
Filing date
01/03/2020
Registration date
09/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2023
Last transaction
09/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/13/2022
First use in commerce
09/13/2022
Drawing code
4
Owner type
03
Owner location
Waltham, MA, US
Examiner
FARRELL, ANNE M
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Orionis Biosciences Inc.
Representatives
Rachelle A. Dubow, Esq. MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic and biological reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancerauto immune diseasesmetabolic diseasesneurological diseasesneuromuscular diseases
Class 5
Pharmaceutical productsserums and preparations for the treatment of cancerauto immune disordersmetabolic disorders; cytokinesreagents for scientific and research use; pharmaceutical preparationscytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparationsantibodiescytokinesantigensenzymesimmunoconjugates for treatment of cancerimmunological conditionsmetabolic disorders; Biochemical preparations for medical purposes for use in the treatment of cancerauto immune diseasesmetabolic diseases
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/05/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/02/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/01/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/30/2023
IUAF
USE AMENDMENT FILED
06/23/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/23/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/10/2023
EX5G
SOU EXTENSION 5 GRANTED
01/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/21/2022
EXT5
SOU EXTENSION 5 FILED
12/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2022
EX4G
SOU EXTENSION 4 GRANTED
06/14/2022
EXT4
SOU EXTENSION 4 FILED
06/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2021
EX3G
SOU EXTENSION 3 GRANTED
12/15/2021
EXT3
SOU EXTENSION 3 FILED
12/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2021
EX2G
SOU EXTENSION 2 GRANTED
06/14/2021
EXT2
SOU EXTENSION 2 FILED
06/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/16/2020
EX1G
SOU EXTENSION 1 GRANTED
12/14/2020
EXT1
SOU EXTENSION 1 FILED
12/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2020
PUBO
PUBLISHED FOR OPPOSITION
04/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2020
DOCK
ASSIGNED TO EXAMINER
03/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2020
NWAP
NEW APPLICATION ENTERED
01/07/2020
Continuous trademark protection
Get notified about every new filing that threatens A-KINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.